Judith Matthews
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Judith Matthews
Earlier roles on record: CFO at Iterum Therapeutics plc (ITRMF) until March 27, 2026. Iterum Therapeutics plc reported in an 8-K filed March 27, 2026 that Judith Matthews resigned as Chief Financial Officer, effective March 27, 2026. Judith Matthews has spoken on 4 earnings calls across 1 company, most recently for Iterum Therapeutics plc on November 14, 2025.
“Also on March 27, 2026, each of Corey Fishman, the Company's President and Chief Executive Officer, and Judith Matthews, the Company's Chief Financial Officer, resigned from their positions with the Company, effective as of immediately following the filing of the Winding Up Petition.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-03-27
-
Start not stated–2026-03-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.